The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Conditions
- Advanced Solid Tumor
- Advanced Malignant Neoplasm
- Metastatic Cancer
- Metastatic Solid Tumor
- Lung Cancer
- Ovarian Cancer
- Endometrial Cancer
- Prostate Cancer
- Colorectal Cancer
- Breast Cancer
- Other Cancer
- Locally Advanced
- Head and Neck Cancer
- Gall Bladder Cancer
- Small Cell Lung Cancer
- Small Cell Lung Cancer ( SCLC )
- Small Cell Lung Carcinoma
- NSCLC
- NSCLC (Non-small Cell Lung Cancer)
- SCLC
- Non-Small Cell Lung Carcinoma
- Triple Negative Breast Cancer
- TNBC
- HER2+ Breast Cancer
- Non-Small Cell Lung Cancer
- ER/PR Positive Breast Cancer
- HER2- Breast Cancer
- HER2-positive Breast Cancer
- HER2-negative Breast Cancer
- ER/PR(+), Her2(-) Breast Cancer
Interventions
- DRUG: rezatapopt
- DRUG: pembrolizumab
Sponsor
PMV Pharmaceuticals, Inc
Collaborators